Ann: Oncosil breakthrough device receives CE Marking approval, page-153

since I obtained my degree in medicine, post grad training in oncology and gastroenterology, masters in the area of oncology, a fair slug of time spent in biopharma R&D and an unquenchable enthusiasm for learning about the subject that goes beyond what small cap biotechs tend to communicate to market to allow discriminating fact from hype.
if you read my posts nowhere have I disputed that they should have got CE and I’ve stated I see some potential in the device.
May I recommend that instead of indulging in theories of skullduggery you reflect on the fact that some posters may have valid observations to offer.